Recent reports have indicated human cytomegalovirus (HCMV) to be associated with human glioblastoma carcinogenesis. In established examples of viral carcinogenesis, viral DNA and one or more of its products have been detected in most tumor cells of biopsies in the majority of cases. To test whether HCMV is associated with human glioblastoma based on this criterion, we measured the number of viral DNA molecules per cell in both frozen and paraffin-embedded tumor biopsies from 58 patients using real-time quantitative PCR (QPCR). Immunohistochemical and fluorescence in situ hybridization (FISH) to detect HCMV proteins and genome was performed in 10 cases using formalin-fixed paraffin-embedded glioblastoma tissues. Southern blotting using DNA extracted from four glioblastoma cell lines together with immunoblotting using the four cell lines and five glioblastoma tissue samples were also performed. We further confirmed the immunoblot bands using liquid chromatography-tandem mass spectrometry assay. As a result, HCMV DNA was not detected in the tumor cells from any of the glioblastoma cases by QPCR detecting two different HCMV genes, in clear contrast to samples from patients with HCMV infection. Southern blotting and immunoblotting of cell lines and FISH using paraffin sections were all negative. However, immunoblotting and immunohistochemistry using tissue samples were partly positive, but HCMV proteins were not detected by proteomic analysis, suggesting false positivity of the analyses. As our QPCR analysis could detect 10 copies of HCMV DNA mixed with DNA extracted from 10 4 HCMV-negative cells, we conclude that HCMV is not persistent, at least in the tumor cells, of developed human glioblastoma.
STAT3 in the vascular niche. The data suggest that HCMV proteins may have a role in genesis of glioblastoma and immunotherapy studies for glioblastoma targeting viral proteins have been attempted in several laboratories. However, Lau et al 5 did not detect any association between HCMV and glioblastomas by conventional PCR and other methods, and another group reported no involvement 6 after analyzing a large number of samples. The role of methodology may be important and Cobbs et al 1 observed that almost all primary tumor specimens from patients with glioblastoma multiforme expressed HCMV immediate early (IE) proteins, whereas adjacent normal cells did not. It is known that the HCMV 72-kDa IE protein (IE72) can enhance cell proliferation, thereby promoting cellular transformation or tumor progression. 7 UL97 protein kinase phosphorylates and inactivates Rb, leading to cellular proliferation, 8 and HCMV infection also is reported to activate human telomerase, preventing replicative senescence. 9 In addition, the US28 protein promoted tumorigenesis when US28-expressing cells were injected into nude mice. Nevertheless, a causal relationship between HCMV infection and cancer has not been established and whether HCMV actually contributes to human glioblastoma oncogenesis in vivo is still unclear. 10 Human papilloma virus and Epstein-Barr virus are well-established examples of viral oncogenesis with human malignancies (reviewed by Psyrri and DiMaio 11 and Shah and Young 12 ). In such cases, viral DNA and proteins are detected in the majority of the tumor cells in a large proportion of cases. If HCMV is the most important risk factor for the genesis of glioblastomas, it might similarly be expected to be detected in tumor cells, that is, the majority of tumor cells within a biopsy each have one or more copies of the HCMV genome.
Real-time quantitative PCR (QPCR) using HCMVspecific primers and appropriate probes is well established for testing viral load of HCMV in clinical samples, 13 with high specificity and sensitivity. 14 Using this method, at least one copy of HCMV genome per 1000 cells can be detected. 15 In this study, we quantitatively measured the number of viral DNA molecules per cell in both frozen and paraffin-embedded tumor biopsies from 58 glioblastoma patients using QPCR. As a result, no positive signals could be detected, and we attempted to perform proteome analysis to identify which proteins contributed to the signals frequently detected in the glioblastoma tumor cells by immunoblotting and immunohistochemistry.
Materials and methods

Patients
Frozen glioblastoma tissues (40 samples) were obtained from 25 patients of Nagoya University Hospital and 15 of Nagoya Central Hospital with written informed consent.
In addition, 19 formalin-fixed, paraffin-embedded glioblastoma samples were obtained from 10 patients of Nagoya University Hospital and 9 of Toyota Kosei Hospital. The patients were 36 men and 22 women, aged 12-84 (mean 55.7, median 61). For positive controls, fresh blood or urine was obtained from two pediatric patients with HCMV infection. Furthermore, formalin-fixed, paraffin-embedded samples were obtained from two adult patients with HCMV reactivation. Cell lysates from fresh frozen tissues from patients #1, 3, 4, 8, 18 in Table 1 were applied for immunoblotting. Paraffin sections from patients #41-50 and #P3 in Table 1 were applied for immunohistochemistry and FISH. The experimental designs in this study were reviewed and approved by the Committee for Bioethics of Nagoya University Graduate School of Medicine (#671 and #830) and Nagoya Central Hospital.
Cell Lines
Human peritoneal mesothelial cells (HPMCs) were established and cultured as previously described. 16 Human foreskin fibroblasts were cultured and infected by HCMV as previously described. 17 The glioblastoma cell lines, T98, U87, SKKG7 and G251 were maintained in Eagle's minimal essential medium supplemented with 10% fetal calf serum (Sigma, St Louis, MO, USA), penicillin (100 U/ml) and streptomycin (100 mg/ml) at 37 1C in 5% CO 2 . These four glioblastoma cell lines were applied for Southern blotting and immunoblotting analyses.
DNA Extraction
DNA was extracted from 10 mm paraffin-embedded sections using a DNeasy Blood and Tissue Kit (Qiagen, Valencia, CA, USA). From frozen tissue samples or cells in culture, genomic DNA was directly extracted using a QIAamp DNA Mini Kit (Qiagen) according to the manufacturer's instructions. Towne 18 HCMV bacterial artificial chromosome (BAC) DNA including the whole genome of HCMV was kindly donated by F Liu (University of California, Berkeley, CA, USA). Plasmid containing IE gene of HCMV was constructed as previously described. Plasmid containing glycoprotein B (gB) gene was constructed by first amplifying the gB gene with the primers described, 19 and cloned into the pGEM-T Easy TA cloning kit (Promega, Madison, WI, USA) according to the manufacturer's protocol. BAC or plasmid DNA was extracted using a Nucleobond PC 20 Plasmid DNA Purification Kit (Macherery-Nagel, Dü ren, Germany) or a plasmid midi prep kit (Qiagen), respectively, according to the manufacturer's instructions.
Real-Time QPCR
Fifty nanograms of isolated genomic DNA were applied per each QPCR reaction. Sample DNA was amplified 50 cycles with an annealing temperature of 55 1C using a Taqman Universal PCR Kit (ABI) and the 7300 real-time PCR system (ABI) following the manufacturer's instructions. PCR products were normalized to human beta-actin using the comparative Ct method. Water was used to test for DNA contamination in the reagents. The primers and probes for gB and major IE gene. 17, 19 Immunoblotting and Immunohistochemical Analyses
Immunoblotting and immunohistochemistry were performed as previously described. 20, 21 Purified human serum albumin (HSA) was obtained from Wako Pure Chemical Industries (#013-10501). Primary antibodies used were IE1/2 (NEA-9221, Perkin Elmer), pp28 (CA004, EastCoast Bio), pp65 (023-A, Virogen) and UL44 (CA006, EastCoast Bio).
Liquid Chromatography-Tandem Mass Spectrometry (LC/MS/MS) Analysis
For LC/MS/MS analysis, bands were visualized using 4-chloro-1-naphtol, excised and then on-membrane digestion was performed mostly similarly to a previous report. 22 LC/MS/MS analysis was performed as previously described. 23 Fluorescence In Situ Hybridization HCMV BAC DNA was labeled with SpectrumOrange using a Nick Translation Kit (Abbott Molecular, Abbott Park, IL, USA) according to the manufacturer's recommendation and FISH analysis for HCMV genome detection was performed as described previously. 24 
Southern Blot Analysis
A HCMV probe was generated by labeling HCMV BAC DNA with [ 32 P]dCTP (Amersham Pharmacia Biotech, Piscataway, NJ, USA) using a Nick Translation Kit and Southern blot analysis was performed as described previously. 17 
Results
QPCR and Southern Blot Analysis
Clinical data of the patients and results for detection of HCMV DNA are summarized in Table 1 Table 1 ). The HCMV copy numbers for urine or blood from two patients with symptoms of HCMV hepatitis and systemic HCMV infection were 39 and 12 336 per reaction, respectively (samples P1 and P2) and 394 and 8826 per reaction, respectively, for formalin-fixed paraffin-embedded samples from two other patients with CMV proctitis or gastritis (samples P3 and P4). The minimum HCMV copy number was 0.002 per cell in these positive control samples. In clear contrast, HCMV DNA for either gB or IE genes was not detected in any of the 59 glioblastoma samples. To confirm that formalin-fixed DNA from HCMV-negative glioblastoma samples, we performed control experiments using 10 000, 1000, 100, 10, 5, 2 and 1 copy (copies) of HCMV BAC DNA admixed in 50 ng of HCMV-negative samples (#41). Positive results in triplicate were detected in samples containing 410 copies of HCMV DNA in both IE and gB primer and probes, but no repetitive positive result were obtained from samples containing five HCMV copies or less. Southern blot analysis was totally negative using DNA extracted from cell lines (Supplementary Figure S1 ).
Immunoblotting and LC/MS/MS
Immunoblotting of proteins extracted from five Japanese glioblastoma cases revealed that relatively clear, positive bands were obtained using IE1 and pp28 antibodies (Supplementary Figure S2A) . Thus, we further performed LC/MS/MS analysis of the excised bands. From the band detected with the IE1 antibody, 69 kDa-sized HSA was specifically detected recurrently with high scores (4200), and from the band detected with the pp28 antibody, peptides of isomers of myelin basic protein (MBP) were most frequently detected with reliable scores (Supplementary Table S2 ). Viral proteins were considered as negative because of the low frequency and score. Thus, we performed immunoblotting using purified HSA and demonstrated that IE1 antibody could bind not only to glioblastoma lysates but also to purified HSA (Supplementary Figure  S2B) . Furthermore, no positive results were obtained using glioblastoma cell lines (Supplementary Figure S2C) . However, we obtained vague to rather intense positive nuclear staining of viral antigens by immunohistochemistry using antibodies against IE1 and pp28 of HCMV (Figure 1 ).
Immunohistochemical Analyses and FISH
Immunohistochemical results of 10 patients (#41-50 in Table 1 ) are summarized in Supplementary Table S1 . Although some of the glioblastoma tumor cells showed rather strong nuclear staining using HCMV antibodies (Figures 1b and c) , no staining was observed using others (Figures 1d and e) , in clear contrast with the positive control sample from an HCMV proctitis patient in which intense nuclear staining was observed by all of the HCMV antibodies (Figures 1g-j) . By FISH analysis, orange fluorescent signals were diffusely observed in the nuclei and perinuclear area of CMV-infected cells using paraffin sections of positive control samples (Figure 1k) , however, no signals were detected in the 10 glioblastoma samples (#41-50 in Table 1 and  Supplementary Table S1 ). Supplementary Table S1 and S2). (f-k). Reactive HCMV proctitis (#P3 in Table 1 ). H&E stain (a, f), immunostaining (b, g: IE1/2; c, h: pp28; d, i; pp65, e, j; UL44), FISH using a HCMV whole genome probe labeled orange (k). 
Discussion
Our QPCR assay demonstrated that the relative copy number of HCMV in all the frozen or formalin-fixed, paraffin-embedded tissues was o10 copies per 10 000 cells, that is, one HCMV genome in 1000 cells. The results are not in line with earlier reports that were interpreted to indicate that HCMV DNA was detectable in a fraction of human glioblastomas, despite the fact that the same region of the HCMV genome were amplified. 25 Recently, another study using 12 primer pairs and semi-QPCR also revealed the significantly higher incidence of CMV-DNA in a proportion of glioblastoma samples compared with non-tumor tissues. 26 One reason for this discrepancy may be because extremely small amount of DNA can be detected by traditional PCR techniques that were utilized such as nested-PCR utilized in the previous study 1 in which 35-50 cycles of amplification followed by a second round of amplification, and HCMV DNA from cells other than the tumor cells were detected. Glioblastoma is often accompanied with reactive gliosis at the edge of the tumor tissue, and microglial cells that originate from bone marrow myeloid cells, which may be persistently infected by HCMV, 27 could have important roles in the development of gliosis. 28 Thus, we consider that these positive PCR results different from ours may be because of relatively smaller content of reactive glial cells in our samples. Another important reason may be because false positivity due to cross-contamination of the samples or incorporation of pre-existing HCMV DNA in the laboratory can easily occur using these PCR-based methods. In our study, negative control wells with no templates were always included in each PCR reaction plate to avoid over-interpretation of falsepositive results. Southern blotting and immunoblotting using DNA and protein extracted from glioblastoma cell lines both revealed negative results. Therefore, we consider that HCMV is negative in the neoplastic cells of developed glioblastoma. However, immunoblotting and immunohistochemistry using tissue samples both showed some positive signals, and nuclear staining was detected by immunohistochemistry not only in the tumor cells but also in the reactive glial cells (Supplementary Figure S2 and Supplementary  Table S1 ). Recent studies suggest that HCMV infection may be important in inducing tumorsupportive monocytes to support the growth of the tumor cells, 29 and also, DNA changes in single cells can influence other neighboring cells either through intracellular connections or paracrine mechanisms or exosomes, 30 Table S1 ). Our FISH analysis is highly sensitive because we probed BAC DNA containing full-length HCMV genome, and in our previous study, we could readily detect two copies of the human genome in a cell using the same method. 24 Earlier studies reporting positive signals of HCMV DNA and RNA in the glioblastoma cells by in situ hybridization utilized antibody-mediated enhancement of the primary signals, 1,2 which may have resulted in augmentation of nonspecific bindings of the probes, leading to misinterpretation of the signals. Furthermore, our LC/MS/MS analysis revealed that proteins extracted from the positive bands detected in immunoblotting using IE1 and pp28 antibodies were non-viral human proteins such as HSA and MBP, suggesting previously unknown cross-reactivity of these antibodies and also the unreliability of not only positive immunoblot bands but also immunohistochemical staining. According to a most recent report performing RNA-Seq analysis using a next-generation sequencer on a large number of human tumor tissues, no viral RNA from DNA viruses such as HCMV was present in either lowgrade or high-grade glial tumors. 31 Taking into account, although there still is a possibility that HCMV-infected cells are present in the brain tissue at certain proportion, it is unlikely that the majority of the tumor cells are persistently infected, and we could not obtain direct evidences to support the hypothesis that exosome secretion of viral RNA and proteins from non-neoplastic cells are the reasons for positive immunoblotting or immunostaining results.
In conclusion, in this study, we analyzed a relatively large number of glioblastoma samples by QPCR, which revealed that all the cases were negative for HCMV viral DNA. Furthermore, we could not detect any viral proteins extracted from positive immunoblot bands using IE1 or pp28 antibody. Thus, we conclude that HCMV genome or proteins are not detectable in human glioblastoma cells.
